A small-scale study has confirmed that 18F-FDG PET scans on pregnant women deliver lower-than-expected radiation doses to the fetus.
A small-scale study has confirmed that 18F-FDG PET scans on pregnant women deliver lower-than-expected radiation doses to the fetus. The study, published this month in theJournal of Nuclear Medicine, was led by Amol Takalkar, MD, of the LSU Health Sciences Center and the Biomedical Research Foundation of Northwest Louisiana in Schreveport.
The retrospective analysis considered five pregnant women with malignancies (two with cervical cancer, two with lymphoma, and one with lung cancer) confirmed through biopsy. All underwent PET-only (no CT) studies with a reduced 18F-FDG dose (173.9 to 340.4 MBq rather than the standard 555 MBq), with the exception of one patient whose pregnancy test was negative immediately before the procedure, who received 583.12 MBq. The patients were given vigorous hydration to minimize radiation exposure to the fetus.
Researchers reviewed six 18F-FDG PET studies (one woman had two studies done), one in early pregnancy, one in the second trimester, and three in the third trimester. The fetal dose exposure from 18F-FDG PET studies was estimated to range from 1.1 to 2.43 mGy for various trimesters in pregnancy (except for the patient in the early stage of pregnancy, in whom activity in the whole uterus was considered, and the fetal dose was estimated to be 9.04 mGy). All patients delivered healthy infants with no visible abnormalities at term.
The researchers concluded that the radiation dose from 18F-FDG PET scans was “quite low and significantly below the threshold for deterministic effects due to radiation exposure to the fetus.”
In addition, Takalkar and colleagues found that the estimated fetal radiation exposure in these five cases was slightly lower than existing estimates on fetal dose exposure, and that, if confirmed by future studies, current fetal dose estimates may need revision.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.